Sector portfolio · Asset manager · United States
Blue Owl's Biotech portfolio
Blue Owl has backed 14 Biotech startups in rounds we track, $4.0B between them, shown by the stage each has reached. The best-funded is Bridgebio.
Funding by segment
- Stage not reported$1.9B5
- Series C and later$1.1B5
- Series B$1.0B4
Where they are based
- United States13$3.7B
- Switzerland1$365M
United States
SwitzerlandFounded
1 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M0
- $10M to $50M0
- $50M to $250M9
- $250M to $1B4
- $1B and over1
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
13 of 14 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States13
- Switzerland1
Startups by country, 2 countries in all.
Segment by segment
Stage not reported
5 startups · $1.9B raised
BridgeBioBridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases and cancers.United States$1.4B
Palvella TherapeuticsPalvella Therapeutics is a clinical-stage biopharmaceutical company based in Wayne, Pennsylvania.United States$210M
Pyxis OncologyPyxis Oncology is a biotechnology firm that develops antibody therapeutics intended to promote the body's immune response to cancer.United States$110M
Context TherapeuticsContext Therapeutics is a clinical-stage biopharmaceutical company.United States$100M
Korro BioKorro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms.United States$85M
Series C and later
5 startups · $1.1B raised
Star TherapeuticsStar Therapeutics is a clinical-stage biotechnology company based in South San Francisco, California, founded in 2018.United States$325M
Obsidian TherapeuticsObsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.United States$210M
Aviceda TherapeuticsAviceda Therapeutics is a clinical-stage biotechnology company based in Cambridge, Massachusetts, founded in 2018.United States$208M
Electra TherapeuticsElectra Therapeutics is a clinical-stage biotechnology company based in South San Francisco, California, founded in 2018.United States$183M
Lycia TherapeuticsLycia Therapeutics is a clinical-stage biotechnology company based in South San Francisco, California.United States$182M
Series B
4 startups · $1.0B raised
Windward BioWindward Bio is a clinical-stage biotechnology company with deep discovery, development, and commercialization expertise committedSwitzerland$365M
Cardurion PharmaceuticalsCardurion Pharmaceuticals is a clinical-stage biotechnology company founded in 2017, focused on developing innovative therapeuticsUnited States$260M
Mirador TherapeuticsMirador Therapeutics is a clinical-stage precision medicine company based in San Diego, California.United States$250M
Syros PharmaceuticalsSyros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.United States$128M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Blue Owl as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like Blue Owl?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.